Pengpeng Su
发表
Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease
H. Cui,
S. Yuan,
Ning Huangfu,
2023,
bioRxiv.
Zhenhua Yan,
Hui Jiang,
Pengpeng Su,
2023,
Sustainability.
Fei Li,
Yan Li,
Qi Xue,
2017,
Oncotarget.
Zhenhua Yan,
Peiyuan Zhu,
Yixin Zhou,
2023,
Frontiers in Marine Science.
Ming Cao,
Pengpeng Su,
Haoyao Chen,
2021,
IEEE Transactions on Instrumentation and Measurement.